Method: PLE20 (Alamanda Polymers, Inc., Huntsville, AL, U.S.A) was dissolved in phosphate buffered saline at a concentration of 0.94mM. HAp discs (20% porosity) used as enamel analogues were located in SMR environmental cells and treated with 0.1M acetic acid at pH 4.0 for 48h. The discs were then washed, and exposed to PLE20 peptide solution for 24h. Demineralisation was then continued for a further 48h. The rate of demineralisation (RDHAp) before and after peptide treatment was measured using SMR.
Results: RDHAp before peptide treatment was 2.18(4) ×10-4gm cm-2h-1 (r2=0.729) and after peptide treatment was 1.57(1) ×10-4gm cm-2 h-1 (r2=0.943). This result demonstrates a significant reduction in RDHAp of ~27% following PLE20 treatment.
Conclusion: This study demonstrates that poly-L-glutamic acid at a concentration of 0.94mM can inhibit the demineralisation of hydroxyapatite (HAp), confirming the role of glutamic acid in HAp demineralisation inhibition, and suggesting its cariostatic potential.